Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TRAW compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
TRAW
Traws Pharma, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
TRAW
Traws Pharma, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
TRAW: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only TRAW
3
—
Temple University
unlisted
supplier
—
Viriom
unlisted
supplier
—
HanX Biopharmaceuticals
unlisted
customer
Shared
0
No shared counterparties.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
25 more · LLY chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
TRAW, solid
LLY, dashed
TRAW
Traws Pharma, Inc.
Change
0.28
▼
−6.52%
· post 0.28
· delayed
Mkt cap
$4.1M
Revenue
$3M
Q2 FY25
Revenue
$3M
FY24
LLY
ELI Lilly & Co
Change
1,417.89
▲
+0.60%
· post 1,417.50
· delayed
After hours
Nov 4 '26
delayed
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
After hours
Nov 4 '26
delayed
TRAW
Traws Pharma, Inc.
vs
LLY
ELI Lilly & Co
0.28
▼
−6.52%
post 0.28
delayed
Price
1,417.89
▲
+0.60%
post 1,417.50
delayed
$4.1M
Mkt cap
$1.3T
Q2 FY25
$3M
Revenue
$24.4B
Q3 FY26
FY24
$3M
Revenue
$65.2B
FY25
Change
Change
TRAW
0.28
▼
−6.52%
vs
LLY
1,417.89
▲
+0.60%
After hours
Nov 4 '26
delayed